`By:
`Peter R. Munson
`Lorelei P. Westin
`
`WILSON SONSINI GOODRICH & ROSATI
`
`Paper No.
`
`12235 El Camino Real
`
`Suite 200
`
`San Diego, CA
`Tel.: 858-350-2300
`
`Fax: 858-350-2399
`
`Email: pmunson@wsgr.com
`Email: 1westin@Wsgr.com
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AGILA SPECIALTIES INC. and MYLAN PHARMACEUTICALS INC.
`
`Petitioners
`
`V.
`
`CUBIST PHARMACEUTICALS, INC.
`
`Patent Owner
`
`Patent No. 8,058,238
`
`PETITIONER AGILA SPECIALTIES INC.’S
`
`POWER OF ATTORNEY
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Agila Specialties Inc., hereby
`
`appoints the practitioners associated with Wilson Sonsini Goodrich & Rosati,
`
`Customer Number 23-2415, including the following lead and back—up counsel, as
`
`its attorneys to transact all business in the United States Patent & Trademark
`
`Office associated with the petition for inter partes review of U.S. Patent No.
`
`8,058,238:
`
`Lead Counsel
`
` Back-Up Counsel
`
`
`
`Lorelei P. Westin
`
`USPTO Reg. No. 52,353
`WILSON SONSINI GOODRICH &
`
`ROSATI
`
`12235 El Camino Real, Suite 200
`San Diego, CA 92130-3002
`Tel.: 858-350-2300
`
`Fax: 858-350-2399
`Email: lwestin@wsgr.com
`
`
`
`
`
`Peter M. Munson
`
`USPTO Reg. No. 43,821
`WILSON SONSINI GOODRICH &
`
`ROSATI
`
`12235 El Camino Real, Suite 200
`San Diego, CA 92130-3002
`Tel.: 858-350-2300
`
`Fax: 858-350-2399
`
`Email: munson@ws r.com
`
`
`
`
`gfldiy I/' 0UI¢C60v\n
`
`
`
`